UnknownNot Applicable

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Netherlands965 participantsStarted 2022-01-01

Plain-language summary

The purpose of this study is to investigate the association between time to treatment (defined as date of pathological diagnosis to date of start treatment) and disease free survival in patients with high risk cutaneous squamous cell carcinoma in the head-neck region.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient diagnosed with high-risk HNcSCCs, defined as T2 to T4 HNcSCC * Treated in the Maastricht University Medical Center+ (MUMC+) or Radboud University Medical Center (RadboudUMC) * Treated between 2010 to 2018 Exclusion Criteria: * Patients aged younger than 18 years * Patients with a T1 HNcSCC * Patients with recurrence or metastatic disease of a previously treated HNcSCC

What they're measuring

Association time to treatment and survival

Timeframe: 5 years after treatment

Trial details

NCT IDNCT05845632

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-01

View on ClinicalTrials.gov More Carcinoma, Squamous Cell trials